Class II — Moderate Risk Severity Status: Ongoing Authority: FDA

TARGET EYE DROPS MAXIMUM REDNESS RELIEF EYE

Recalling Firm / Manufacturer: K.C. Pharmaceuticals, Inc. (Pomona, CA, United States)

FDA Recall Number: D-0005-2027

Source Authority Disclaimer: This drug recall notice is published by Questo using official enforcement reports issued by the U.S. Food & Drug Administration (FDA). It is provided for informational, academic, and clinical research purposes only. Patients should not discontinue prescribed treatments without consulting their physician or pharmacist.

Product & Identification Information

Brand, active ingredients, NDC codes, and manufacturer details

Brand / Trade Name

TARGET EYE DROPS MAXIMUM REDNESS RELIEF EYE

Generic Name

GLYCERIN, NAPHAZOLINE HYDROCHLORIDE

Active Substance(s)

Glycerin, Naphazoline Hydrochloride

Administration Route

Ophthalmic

National Drug Code (NDC)

11673-100

Total Quantity Recalled

1,435,830 cartons

Official Reason for Recall

Specific hazard or quality defect cited by the FDA

According to the official FDA enforcement report:

Lack of Assurance of Sterility

Full Product Description

Packaging specifications and labeling details

Eye Drops MAXIMUM, REDNESS RELIEF, Sterile, 1/2 FL OZ (0.5 ML); a) exchange select, Manufactured for your Military Exchange By: K.C Pharmaceuticals, Inc., Pomona, CA 9176, UPC: 6 14299 89636 9; b) Harris Teeter, PROUDLY DISTRIBUTED BY: HARRIS TEETER, LLC, MATTHEWS, NC 28105, UPC: 0 72036 73589 8; c) TYSON, MIKE RED EYE DROPS, Distributed by: JBRANDS Distribution, Miami, FL 33009, UPC: 7 84847 57549 4; d) up & up, Distributed by: Target Corporation, Minneapolis, MN 55403, NDC 11673-100-01; e) TopCare health, DISTRIBUTED BY TOPCO ASSOCIATES LLC, ELKGROVE VILLAGE, IL 60007, UPC 0 36800 21123 0; f) Walgreens, DISTRIBUTED BY: WALGREEN CO. 200 WILMOT RD, DEERFIELD, IL 60015, UPC 3 11917 20075 0.

Enforcement & Regulatory Details

FDA classification, report dates, and initiation authority

Health Hazard Classification

Class II

Current Action Status

Ongoing

FDA Enforcement Report Date

October 14, 2026

Firm Initiation Date

September 11, 2026

FDA Classification Date

Oct 05, 2026

Initiation Type

Voluntary: Firm initiated

Affected Lots & Batch Numbers

Product codes, lot numbers, and expiration dates

Lot: a) CM25E02, Exp.: 5/31/2027; CM25M01, Exp.: 10/31/2027; b) CM25E02, Exp.: 5/31/2027; c) CM25C01, Exp.: 3/31/2027; CM25C02, Exp.: 3/31/2027; CM25C03, Exp.: 3/31/2027; CM25E02, Exp.: 5/31/2027; CM25F01, Exp.: 6/30/2027; CM25A02, Exp.: 1/1/2027; CM25B01, Exp.: 2/28/2027; d) CM25B01, Exp.: 2/28/2027; CM25E01, Exp.: 5/31/2027; CM25E02, Exp.: 5/31/2027; CM25K01, Exp.: 9/30/2027; CM25M01, Exp.: 10/31/2027; e) CM25B01, Exp.: 2/28/2027; CM25F01, Exp.: 6/30/2027; CM25K01, Exp.: 9/30/2027; CM25M01, Exp.: 10/31/2027; f) CM25B01, Exp.: 2/28/2027; CM25E02, Exp.: 5/31/2027; CM25K01, Exp.: 9/30/2027; CM25M01, Exp.: 10/31/2027.

Distribution Information

Geographic scope of affected shipments

US Nationwide

Safety Guidance & Actions

Standard FDA protocol for patients and healthcare providers

Patient Advisory

Check your prescription bottle or packaging against the affected lot numbers listed above. If your medication matches a recalled lot, contact your pharmacist for replacement guidance.

Healthcare Provider Guidance

Audit pharmacy stock and return affected lots to the distributor per manufacturer instructions. Notify patients where clinically indicated.

Related Questo Medical Knowledge

Clinical cases and condition overviews related to this medication

Official Source Provenance

Verified regulatory citation from U.S. FDA OpenFDA

Primary Data Source: U.S. Food & Drug Administration (FDA) OpenFDA API

Recall Number: D-0005-2027

Questo Retrieval Date: October 21, 2026 00:00 1792540811UTCC

View Official FDA Source

TARGET EYE DROPS MAXIMUM REDNESS RELIEF EYE

Official Source Provenance

Create an Account to Continue

System Notice

Confirm Action